Objective To study the occurrence situation of suspected adverse event cases of immunization (AEFI) in Wuhu county and to study the security of conventional and intensification vaccination, so as to provide a scientific basis for immunization planning decisions. Methods AEFI data during the period of 2014-2016 were collected through the AEFI Monthly Routine Report System of Wuhu county and the China Information System for National Immunization Program (NIP). The descriptive methodology was used to conduct epidemiological analyses. Results 74 AEFI cases were reported from 2014 to 2016, there were 60 (81.08%) cases with general reactions and 14 (18.92%) cases with paradoxical reactions. There were 13 kinds of vaccines involved in AEFI cases. The reported incidence of AEFI was 29.80/105, the general reactions incidence was 24.16/105 and the paradise incidence was 5.64/105. The reported and investigated rates within 48h were 94.59% and 100%. 95.95% AEFI cases occurred within 1 day after vaccination. Cases mainly happened in young who were 4 years old or less. The clinical diagnosis of AEFI cases were fever, flare, induration and anaphylaxis. 85.14% of AEFI cases occurred because of the first class vaccinations, these cases included DTaP vaccine (22.97%), MCV-A+C vaccine (16.22%) and MR vaccine (8.11%) and so on. There were statistics significance between the general reactions of NIP vaccination and the second type of vaccine the abnormal reactions were no different. Conclusion The AEFI monitoring system was running in good condition in Wuhu county. It is necessary to strengthen the specification disposal,specify the technological process and operation of vaccination,and pay attention to the publicity and education and risk communication of AEFI.Then we can reduce the occurrence rate of AEFI.
Key words
Adverse event following immunization /
Data analysis /
Monitor
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 张晋琳,汪志国,马福宝. 江苏省2008年疑似预防接种异常反应监测数据的分析评价[J]. 微生物学免疫学进展,2010,38(1):40-45.
[2] 卫生部,国家食品药品监管局. 全国疑似预防接种异常反应监测方案[S].卫办疾控发〔2010〕94 号. 2010-06-03.
[3] 张延龄,张辉. 疫苗学[M]. 北京:科学出版社,2006:125-130.
[4] 谢广中,刁连东,王树巧,等. 预防接种的反应和处理[M].3版.上海:上海科技出版社,2009:41-48.
[5] 武文娣,刘大卫,吴冰冰,等. 全国2007-2008年疑似预防接种异常反应监测分析[J]. 中国疫苗和免疫,2009,15(6):481-490.
[6] 武文娣,刘大卫,李克莉,等. 全国2009年疑似预防接种异常反应监测分析[J]. 中国疫苗和免疫,2011,17(2):99-108.
[7] 刘葆钧.b型流行性感冒嗜血杆菌疫苗、白百破及灭活脊髓灰质炎混合成五联疫苗在同一注射器中给婴儿接种的安全性和免疫原性[J].中国计划免疫,2001,7(6):344.
[8] 李艳萍,李凤祥,侯启明.中国婴幼儿接种吸附无细胞百白破灭活脊髓灰质炎和Hib(结合)联合疫苗的安全性及免疫原性研究[J]. 中华流行病学杂志,2011,32(8):808-815.
[9] 张丽,美国疫苗不良反应报告系统可用于提高疫苗的信任度和接受度吗?[J].中华预防医学杂志,2016,50(7):610.